ALASTAIR THOMPSON to Hypoglycemic Agents
This is a "connection" page, showing publications ALASTAIR THOMPSON has written about Hypoglycemic Agents.
Connection Strength
0.670
-
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial. Breast Cancer Res Treat. 2011 Aug; 128(3):783-94.
Score: 0.290
-
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res Treat. 2009 Mar; 114(2):391.
Score: 0.234
-
Molecular pathways: preclinical models and clinical trials with metformin in breast cancer. Clin Cancer Res. 2014 May 15; 20(10):2508-15.
Score: 0.088
-
Targeting AMPK: a new therapeutic opportunity in breast cancer. Crit Rev Oncol Hematol. 2008 Jul; 67(1):1-7.
Score: 0.058